Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y‐labeled anti‐podoplanin antibody NZ ‐12 for mesothelioma-Reference-Cited by-同舟云学术

Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y‐labeled anti‐podoplanin antibody NZ ‐12 for mesothelioma

Published:2019-03-12 Issue:5 Volume:110 Page:1653-1664
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sudo Hitomi¹,Tsuji Atsushi B.¹^ORCID,Sugyo Aya¹,Saga Tsuneo²^ORCID,Kaneko Mika K.³,Kato Yukinari³⁴^ORCID,Higashi Tatsuya¹

Affiliation:

1. Department of Molecular Imaging and Theranostics National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology (QST‐NIRS) Chiba Japan

2. Department of Diagnostic Radiology Kyoto University Hospital Kyoto Japan

3. Department of Antibody Drug Development Tohoku University Graduate School of Medicine Sendai Miyagi Japan

4. New Industry Creation Hatchery Center Tohoku University Sendai Miyagi Japan

Funder

Core Research for Evolutional Science and Technology

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13979

Reference53 articles.

1. Advances in Malignant Mesothelioma

2. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma

3. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients

4. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

5. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical application of the monoclonal antibody SKM9-2 against sialylated HEG1, a new precision marker for malignant mesothelioma;Proceedings of the Japan Academy, Series B;2023-02-10

2. Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms;Current Drug Targets;2022-12

3. Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2022-08-01

4. Development of a Monoclonal Antibody PMab-295 Against Elephant Podoplanin;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2022-08-01

5. Roles of Podoplanin in Malignant Progression of Tumor;Cells;2022-02-07